Physician profile
Matthew E Schmidt
NPI 1194860395
$4,200.36
in general payments reported to CMS, 2019-2025
22 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $174 · 2021: $541 · 2022: $264 · 2023: $570 · 2024: $492 · 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,778 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,777.55 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $622.25 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $571.50 | 2022-2025 | Lumigan, Alphagan P, Durysta |
| Alcon Vision LLC | $560.10 | 2019-2025 | Rocklatan, Centurion, Tryptyr |
| Sun Pharmaceutical Industries INC. | $312.40 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Allergan, INC. | $310.39 | 2019-2021 | |
| Harrow Eye, LLC | $233.47 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $209.30 | 2019-2023 | |
| Rxsight INC | $202.73 | 2022-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $192.99 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $170.92 | 2019-2021 | |
| Dompe US, INC. | $159.50 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $114.50 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Itamar Medical INC | $107.55 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $89.31 | 2024-2025 | Xdemvy |
| Thea Pharma INC. | $86.10 | 2023-2025 | Iyuzeh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $75.84 | 2025 | Clearpath, Via360, Streamline |
| Amgen INC. | $63.66 | 2024-2025 | Tepezza |
| Shire North American Group INC | $38.56 | 2019 | |
| Akorn Operating Company LLC | $26.31 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.43 | 2021 | |
| Abb Con-Cise Optical Group LLC | $17.90 | 2025 | Contact Lens, Spectacle Lenses |
| Horizon Therapeutics Plc | $16.65 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.